Most cancer drugs today work by attacking tumor growth. Researchers at the University of Michigan Life Sciences Institute, however, are taking aim at a different piece of the cancer puzzle -- preventing its ability to spread to new parts of the body, known as metastasis, which is the cause of most cancer deaths.
University of Michigan Comprehensive Cancer Center experts will discuss breast cancer risks (and how you can reduce yours), as well as screening, treatment and research at a free Breast Cancer Summit on Saturday, April 9, at the University of Michigan North Campus Research Complex.
A new study finds most cancer screening guidelines do not clearly spell out the benefits and harms of the recommended actions.
A new study suggests that up to 60 percent of the CT scans, bone scans, and PET scans performed for more than 29,000 Michigan women diagnosed with early breast cancer between 2008 and 2014 could not be medically justified based on retrospective record review.
A new study suggests that one approach to watching for a cancer’s return is being inappropriately used at many hospitals. And it isn’t helping patients survive longer, the research shows.
Researchers at the University of Michigan Kellogg Eye Center have developed a new nanoparticle that uses a tumor cell’s protective mechanism against itself — short-circuiting tumor cell metabolism and killing tumor cells.
One of the most common cancer-causing genes has continuously stymied researchers’ efforts to develop treatments against it. Now, researchers have dug deeper and exposed a key interaction that may contribute to why mutations in KRAS lead to cancer.
Cancer Center researcher Max S. Wicha has received a $6.5 million Outstanding Investigator Award to study cancer stem cells, the small number of cells within a tumor that fuel its growth and spread.
In response to low national vaccination rates for the human papillomavirus, the University of Michigan Comprehensive Cancer Center has joined 69 of the nation’s top cancer centers in issuing a statement urging for increased HPV vaccination for the prevention of cancer.
Nearly 15 percent of patients diagnosed with colorectal cancer were younger than 50, the age at which screening recommendations begin.